The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: Data from the Italian cohort of ipilimumab expanded access programme (EAP).
Paolo Antonio Ascierto
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Novartis; Roche/Genentech
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
Ester Simeone
Honoraria - Bristol-Myers Squibb
Vanna Chiarion-Sileni
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche/Genentech
Paola Queirolo
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Michele Del Vecchio
Research Funding - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Novartis; Roche/Genentech
Lorenza Di Guardo
No relevant relationships to disclose
Massimo Guidoboni
No relevant relationships to disclose
Paolo Marchetti
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Novartis; Sanofi
Other Remuneration - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Gian Carlo Antonini Cappellini
No relevant relationships to disclose
Pier Francesco Ferrucci
Consultant or Advisory Role - Delcath Systems
Honoraria - Delcath Systems
Francesco Cognetti
No relevant relationships to disclose
Maria Grazia Bernengo
Consultant or Advisory Role - Bristol-Myers Squibb
Michele Guida
No relevant relationships to disclose
Riccardo Marconcini
No relevant relationships to disclose
Mario Mandala
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Giorgio Parmiani
Consultant or Advisory Role - CureVac
Other Remuneration - Recombio
Gaetana Rinaldi
No relevant relationships to disclose
Massimo Aglietta
No relevant relationships to disclose
Luana Calabro
No relevant relationships to disclose
Michele Maio
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb